Page 6 - Therapy Development News Today

Nyxoah Issues First Quarter 2021 Results Mont-Saint-Guibert, Belgium - June 10, 2021, 11:45pm CET / 5:45pm ET - Nyxoah SA (Euronext Brussels: NYXH) ("Nyxoah" or the "Company"), a medical technology

Terumo is building a Global Therapeutic Interventional Oncology team to offer more therapeutic solution to cancer patients News provided by Share this article Share this article LEUVEN, Belgium, April 12, 2021 /PRNewswire/ -- Terumo is proud to announce the launch of its Global Therapeutic Interventional Oncology team as of April 1st, 2021. This reflects Terumos aspiration to be a Global leader in the field of Interventional Oncology by focusing on improving patients quality of life and surviva...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Nyxoah Reports Full Year 2020 Results NyxoahApril 9, 2021 GMT Conference call and webcast today at 3pm CET / 9am ET Mont-Saint-Guibert, Belgium – 9 April 2021 – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial...

Share this article Share this article ResearchAndMarkets.coms offering. The global cell lysis market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 7.2% from 2021 to 2026. Growth in this market is driven by the increasing government funding for research, high prevalence of diseases, and growing focus on personalized medicine. Consumables segment to witness the highest growth during the forecast period. Based on the product, the cell lysis market is...